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Abstract
In this preliminary study we investigated the relationship between the time of cerebral desaturation episodes (CDEs), the 
severity of the haemorrhage, and the short-term outcome in patients with aneurysmal subarachnoid haemorrhage (aSAH). 
Thirty eight patents diagnosed with aneurysmal subarachnoid haemorrhage were analysed in this study. Regional cerebral 
oxygenation  (rSO2) was assessed using near infrared spectroscopy (NIRS). A CDE was defined as  rSO2 < 60% with a duration 
of at least 30 min. The severity of the aSAH was assessed using the Hunt and Hess scale and the short-term outcome was 
evaluated utilizing the Glasgow Outcome Scale. CDEs were found in 44% of the group. The total time of the CDEs and the 
time of the longest CDE on the contralateral side were longer in patients with severe versus moderate aSAH [h:min]: 8:15 
(6:26–8:55) versus 1:24 (1:18–4:18), p = 0.038 and 2:05 (2:00–5:19) versus 0:48 (0:44–2:12), p = 0.038. The time of the long-
est CDE on the ipsilateral side was longer in patients with poor versus good short–term outcome [h:min]: 5:43 (3:05–9:36) 
versus 1:47 (0:42–2:10), p = 0.018. The logistic regression model for poor short-term outcome included median ABP, the 
extent of the haemorrhage in the Fisher scale and the time of the longest CDE. We have demonstrated that the time of a CDE 
is associated with the severity of haemorrhage and short-term outcome in aSAH patients. A NIRS measurement may provide 
valuable predictive information and could be considered as additional method of neuromonitoring of patients with aSAH.
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1 Introduction
Aneurysmal subarachnoid haemorrhage (aSAH) is a dev-
astating condition that can lead to neurological disability, 
impairment of brain perfusion or even death. Although 
aSAH is not the most common type of stroke, it constitutes 
a burden to society since a limited number of aSAH patients 
are able to return to normal daily-life activities [1]. The 
main goal of therapy in aSAH patients is to ensure adequate 
brain perfusion to accomplish metabolic demand. A serious 
imbalance between oxygen supply and demand can lead to 
hypoxia, inflammation, blood–brain barrier impairment, the 
release of vasoconstrictors, or the development of early brain 
injury (EBI). In recent research, EBI has been suggested 
to be a major cause of further complications, disability or 
death in aSAH [2]. Early warning concerning a decrease in 
cerebral oxygenation could minimize the risk of hypoxia 
and EBI [3]. Monitoring of the cerebral blood flow and cer-
ebral oxygenation can significantly improve the efficiency 
Electronic supplementary material The online version of this 
article (https ://doi.org/10.1007/s1087 7-019-00377 -x) contains 
supplementary material, which is available to authorized users.
 * Agnieszka Uryga 
 agnieszka.uryga@pwr.edu.pl
1 Department of Anesthesiology and Intensive Care, Wroclaw 
Medical University, Wroclaw, Poland
2 Department of Biomedical Engineering, Faculty 
of Fundamental Problems of Technology, Wroclaw 
University of Science and Technology, Wybrzeze 
Wyspianskiego 27, 50–370 Wroclaw, Poland
3 Department of Clinical Neurosciences, Division 
of Neurosurgery, University of Cambridge, Cambridge, UK
706 Journal of Clinical Monitoring and Computing (2020) 34:705–714
1 3
of intensive care and applied therapy as well as reduce the 
risk of poor outcome [4, 5]. Cerebral oxygenation could be 
monitored using invasive methods, such as brain microdi-
alysis or thermal diffusion flowmetry [6]. The most common 
methods employed in clinical practise include brain tissue 
partial oxygen pressure  (PtiO2) and jugular venous-oxygen 
saturation  (SjvO2) [7]. Near-infrared spectroscopy (NIRS) 
is an alternative and promising, non-invasive technique, 
which continuously assesses regional cerebral saturation 
 (rSO2) in bedside mode with high spatial and temporal res-
olution. NIRS allows for continuous, long-time monitoring 
of  rSO2 in neurocritical care patients, e.g. after traumatic 
brain injury (TBI) [8], subarachnoid haemorrhage (aSAH) 
[9] or sepsis [10]. As a non-invasive method, it could be 
applied at an early stage of brain damage and continuously 
used in subsequent days after the acute phase. NIRS consists 
in the emission of near-infrared light (NIR) and measures 
the absorbance of NIR by oxy-hemoglobine (oxy-HB) and 
deoxy-hemoglobine (deoxy-HB) according to the Beer-
Lambert law [11]. NIRS is widely applied during cardio-
vascular or cardiopulmonary procedures to provide informa-
tion about significant decreases in cerebral oxygenation in 
order to prevent neurological damage or cerebral injury [12]. 
Moreover, it has been shown that time-resolved NIRS can 
predict and confirm an angiographic-proven vasospasm [13]. 
Few researchers have analysed the association between cer-
ebral oxygen desaturation, based on the  rSO2 measurements, 
and early and late cognitive decline or outcome in aSAH 
patients. Previous studies have focused either on the effec-
tiveness of neuromonitoring using NIRS to obtain clinically 
relevant information in patients with cerebral vasospasm 
and delayed cerebral ischemia [4, 13] or on the possibility 
to monitor cerebral autoregulation using tissue oxygena-
tion index, based on NIRS measurements [9]. In this paper 
we investigated the relationship between the time-related 
parameters of cerebral desaturation episodes, the severity 
of haemorrhage and short-term outcome in aSAH patients.
2  Methods
2.1  Setting and ethics
From January 2015 to December 2017, 46 patients with 
aSAH were hospitalized in the Intensive Care Unit of 
Wroclaw University Hospital. All subjects were adults 
(age ≥ 18 years), had an aneurysm in cerebral arteries which 
was confirmed to be the cause of bleeding using computer 
tomography (CT), magnetic resonance imaging (MRI) or 
conventional angiography and underwent continuous mul-
timodal monitoring using Intensive Care Monitor system 
(ICM+; https ://icmpl us.neuro surg.cam.ac.uk). The exclu-
sion criteria included the lack of written informed consent 
from participant or their legal representatives, death within 
the first 72 h from admission, changes in follow-up postop-
erative CT scan of the head, intracerebral hematoma, previ-
ously diagnosed cardiovascular disease or central nervous 
system disease. Eventually, the study group consisted of 38 
patients with aSAH, who met the inclusion criteria.
The study complied with the Declaration of Helsinki of 
the World Medical Association. Each patient was assigned 
a study identification number and the data was anonymised 
prior to the analysis.
2.2  Subjects and patient treatment
All aSAH patients who entered the study were treated in the 
ICU unit according to current guidelines [14]. Information 
was collected on hypertension, smoking or other medical 
risk factors (diabetes, mellitus etc.) before the ictus. Patient’s 
condition was assessed using the Glasgow Coma Scale 
(GCS), Full Outline of UnResponsiveness scale (FOUR) and 
Acute Physiology and Chronic Health Evaluation II scale 
(APACHE II). The severity of the aSAH was evaluated with 
the Hunt and Hess (H–H) scale, and the extent of bleeding 
was graded using the Fisher scale. Decisions on surgical 
clipping or endovascular coiling of the ruptured aneurysm 
were based on the patient’s condition and medical indica-
tions and performed within 24 h after the initial bleeding. A 
control CT scan was performed within 24 h after aneurysm 
clipping or coiling.
The treatment algorithm was standardised and included 
euvolemia, analgesia, sedation and catecholamines sup-
port when indicated. Patients were mechanically ventilated 
(bilevel positive airway pressure respiration with controlled 
respiratory mode, BiPAP) or received passive oxygen ther-
apy. During ICU follow-up, normovolemia and mean arterial 
pressure (MAP) were maintained above 80 mm Hg and the 
systolic pressure was 160 to 180 mm Hg. CVP value was 
maintained between 5 and 8 mm Hg. Patient’s volume sta-
tus was determined based on central venous pressure (CVP) 
value, heart rate (HR), arterial blood pressure (ABP), fluid 
balance, and urine output. In the group of patients with 
cerebral vasospasm (CV) and those with delayed cerebral 
ischemia (DCI), induced hypertension was used to improve 
cerebral circulation. In this group of patients, norepineph-
rine was used as a first choice treatment due to its com-
bination of α-adrenergic and β-adrenergic receptors stimu-
lation, and the resulting reliable haemodynamic response 
[15]. The improvement of cardiac output was the second-line 
treatment following optimization of arterial pressure; thus, 
milrinone, a selective phosphodiesterase III inhibitor, was 
used. Isotonic fluids were used to correct hypovolemia and 
to maintain the euvolemic state. Nimodipine was admin-
istered to all patients with aSAH to improve neurological 
outcome [16].
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Neurological examinations were performed by intensiv-
ists daily to detect neurological impairment (movement dis-
orders, mental disorders, aphasia). Outcome was assessed 
during the patient’s stay in the ICU and then in the Neuro-
surgery Unit. A good short-term outcome was classified as 
3–5 and poor as 1–2 in the Glasgow Outcome Scale (GOS). 
The CV was defined as the mean cerebral blood flow veloc-
ity (CBFV) in the middle cerebral artery (MCA) exceeding 
120 cm/s or a daily increase of CBFV of ~ 20%, when meas-
ured using Transcranial Doppler ultrasonography (TCD) 
[17]. The ‘ipsilateral’ side was defined as the side of the 
vasospasm (if occurring) or the side of the aneurysm (in 
patients without vasospasm). A DCI was defined as a new 
focal or global neurological impairment that lasted for at 
least 1 h and cerebral infraction, not caused by other factors 
(e.g. systemic complications, surgical complications, etc.) 
[18].
2.3  Regional cerebral desaturation
A regional cerebral desaturation episode (CDE) [19] was 
defined as  rSO2 < 60% for at least 30 min duration [20, 
21]. A patient who had at least one CDE during continu-
ous monitoring was classified as having deficient regional 
cerebral saturation. We introduced the following parameters 
to describe the CDEs which occurred during NIRS-based 
continuous  rSO2 monitoring: the total number of cerebral 
desaturation episodes  (CDEn), the total time of the cerebral 
desaturation episodes  (CDEt), and the time of the long-
est cerebral desaturation episode  (CDEm). The exemplary 
time trend of  rSO2 for the ipsilateral side with definitions of 
 CDEn,  CDEt, and  CDEm is presented in Fig. 1.
2.4  Cerebral autoregulation
Cerebral autoregulation (CA) was analysed using multi-
modal monitoring of slow-wave oscillations and assessed 
using the tissue oxygenation index (TOxa). The TOxa was 
calculated as a moving linear correlation coefficient between 
signals of arterial blood pressure (ABP) and  rSO2. A pres-
sure reactivity index (PRx) was defined as the moving lin-
ear correlation coefficient between signals of ABP and ICP. 
Each of these indices was calculated in overlapping periods 
of 300 s and updated every 60 s [9]. A disturbed CA was 
defined as a median ipsilateral or contralateral TOxa above 
0 [a.u.] [22].
2.5  Data acquisition
Signal monitoring was performed according to current 
guidelines [23], started in the ICU within the first 24 h after 
initial bleeding and continued until the patient’s discharge 
Fig. 1  The exemplary time trend of regional cerebral saturation 
 (rSO2) on the ipsilateral side in a 61 year old woman with aSAH. The 
following time-related parameters were defined: the number of cer-
ebral desaturation episodes  (CDEn), the total time of cerebral desatu-
ration episodes  (CDEt), and the time of the longest cerebral desatura-
tion episodes  (CDEm)
708 Journal of Clinical Monitoring and Computing (2020) 34:705–714
1 3
or when medically required. The  rSO2 was monitored using 
an NIRS monitor (Casmed Fore-Sight monitor, Branford, 
Connecticut, The United States). The probe holder was posi-
tioned over the frontal lobe. A pressure transducer (Argon 
Standalone DTX Plus™, Argon Medical Devices Inc. Plano, 
TX, USA) was used to invasively measure ABP in the radial/
femoral artery. The CBFV in the MCA was collected using 
a TCD with a 2 MHz probe (Doppler BoxX, DWL Com-
pumedics Germany GmbH, Singed, Germany). The CBFV 
was monitored, when medically required, for a half an hour 
per day and the measurements were repeated at least two 
times in subsequent days. The systolic value of the CBFV 
was defined as the maximum value of the CBFV during a 
single cardiac cycle. The ICP was collected using intraparen-
chymal fibre-optic and piezoelectric ICP sensors (Codman 
ICP Monitoring System, Johnson & Johnson Professional, 
Raynham, MA, USA) in patients after surgical clipping. In 
the group of patients with induced hypertension or inotropic 
support, haemodynamic parameters of the cardiovascular 
system were monitored using FloTrac (Edwards Lifesciences 
Irvine, CA USA), including the following: cardiac output 
(CO), cardiac index (CI), stroke volume (SV), and variabil-
ity of stroke volume (SVV). Since the above signals were 
recorded during monitoring in limited group of patients, 
they were not analysed in this study. Data acquisition was 
performed with 200 Hz frequency using the Intensive Care 
Monitor System (Cambridge Enterprise Ltd, Cambridge, 
UK). All artefacts were selected manually or by using cus-
tom-written algorithms, and further analysis was performed 
on the representative part of the signals with Matlab® soft-
ware (MathWorks®, Natick, Massachusetts, USA).
2.6  Statistics
Statistical analysis was performed using STATISTICA 
version 12 (StatSoft, Inc., Tulsa, USA). Since the hypoth-
esis of normality was rejected based on the Shapiro–Wilk 
test with the Lilliefors correction for most of the analysed 
variables, non-parametric tests were applied. Differences 
in the parameters between the two groups, categorised by 
any dichotomised criteria defined in this study, were tested 
using the U Mann–Whitney test (median values) or Fisher’s 
exact test for the contingency table (number of subjects). A 
logistic regression model, which was built using backward 
stepwise elimination, was used to predict mortality risk. The 
significance of the model was assessed using the following 
statistics: Likelihood-Ratio test, the value of  R2 Cox-Snell 
and  R2 Negelkerke. The Area Under the Curve (ROC) and 
the Hosmer–Lemeshow test were applied to determine the 
goodness of the model’s fit (p-value > 0.05 indicating no 
evidence of poor fit). The results are presented as medians 
(interquartile ranges (IQR), 25th–75th percentile).
3  Results
3.1  Patient characteristics and signal monitoring
There were 38 patients retrospectively enrolled to this study, 
where 66% of the subjects were women. The median age was 
57 ± 22 (min:29, max:83) [years]. The median H–H score 
was 3 and the GCS score was 12. The clinical characteristics 
of patients are presented in Table 1. In 29 patients (76% of 
the total group), aneurysms were located in the supratento-
rial region of the brain, whereas nine subjects (24% of the 
total) had aneurysms in the vertebra-basilar circulation. Nine 
patients died (24%) and 10 patients (26%) had poor short-
term outcome. CV was diagnosed in 14 patients (37% of 
the entire group) on mean 4 ± 3 day after onset (min 1 day, 
max 7 day), whereas DCI was found in 13 subjects (34% of 
the total group). The ABP and  rSO2 signals were monitored 
in all patients (n = 38, 100%). The ICP was recorded in 17 
subjects (45% of the total group) and the CBFV was moni-
tored in 29 (76% of the total group). The mean time of signal 
monitoring was 7 ± 4 days (min. 1 day, max. 16 days). The 
median values of the monitored parameters and CA indices 
from the whole monitoring time are presented in Supple-
mentary Table 1.
3.2  Cerebral desaturation episodes
CDEs occurred in 17 patients (44% of the total group) of 
which 7 patients had CDEs on both sides of the brain and 
10 patients had CDEs only on one side (4 patients on the 
ipsilateral side, 6 on the contralateral side). In the group 
of patients with CDEs, 6 died, which is 67% of the total 
cases that resulted in death. The exemplary time trends of 
the monitored signals during the CDEs on both sides are pre-
sented in Fig. 2. Median values of the ipsilateral (p = 0.02) 
and contralateral (p = 0.01)  rSO2 were significantly lower in 
the group with CDEs than the respective values in the non-
CDE group, see Supplementary Table 1. Comparisons of the 
clinical parameters in the groups with and without CDEs are 
presented in Table 1. There was a significant difference in 
the H–H grades for patients with or without a CDE (4 scores 
vs. 2 scores, p = 0.016). Furthermore, patients with a CDE 
had a worse short-term outcome in the GOS scale (median 
GOS grade 3) than patients without a CDE (median GOS 
grade 5), p = 0.013.
3.3  Cerebral desaturation episodes versus cerebral 
autoregulation
We found that ipsilateral TOxa was disordered in 27 patients 
(71%) and contralateral TOxa was impaired in 26 patients 
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(68%) of the total group. In the analysed cohort 7 out of 9 
cases resulting in death (78%) were in patients who suffered 
from a disturbed CA. Disturbances in CA during a CDE 
were found in 6 patients ipsilaterally (6/11; 55%) and 10 
contralaterally (10/13; 77%). In most of the analysed sub-
jects, the disturbances in CA were found both before and 
during the CDEs (see Fig. 2). PRx was calculated only in 6 
patients with a CDE (6/17; 35%); however, we observed that 
the values of PRx corresponded with the respective TOxa 
values and indicated a disturbed CA: median PRx during the 
CDEs: 0.284 (0.157–0.489) [a.u.].
3.4  Parameters of CDEs
In the entire group, the  CDEn was 3 for the ipsilateral 
side and 4 for the contralateral side. The median values of 
 CDEn,  CDEt, and  CDEm in aSAH patients, categorized by 
the severity of the haemorrhage and short-term outcome, 
are shown in Table 2. Patients with severe haemorrhage in 
the H–H scale had a longer  CDEt on the contralateral side 
than the ones with moderate haemorrhage [h:min]: 8:15 
(6:26–8:55) versus 1:23 (1:19–4:17), p = 0.038. Further-
more, patients with severe aSAH had a significantly longer 
Table 1  Patient characteristics in the total group of aSAH patients with and without cerebral desaturation episodes (CDEs)
Data are presented as median ± interquartile range or as the number of subjects (% of the group)
APACHE II acute physiology and chronic health evaluation II, GCS glasgow coma scale, FOUR full outline of unresponsiveness scale, H–H hunt 
and hess scale, EVD external ventricular drainage, DCI delayed cerebral ischemia, CV cerebral vasospasm, GOS glasgow outcome scale
p-value refers to the results of the U Mann–Whitney test (marked as *) or Fisher’s exact test for the contingency table (marked as #)
Statistical significant values were marked in bold
Parameter Total group (N = 38) CDEs (N = 17) Non-CDEs (N = 21) p-value
Age (years) 57 ± 22 57 ± 19 56 ± 20 n.s.*
Gender (women), n 25 12 (71%) 13 (62%) n.s.#
Risk factors
 Hypertension, n 18 (47%) 9 (53%) 9 (43%) n.s.#
 Smoking, n 23 (61%) 10 (59%) 1 (5%) n.s.#
 Other, n 4 (11%) 1 (6%) 3 (14%) n.s.#
 None, n 2 (5%) 1 (6%) 1 (5%) n.s.#
Clinical features
 Apache II grade 14 16 11 n.s.*
 GCS grade 12 13 14 n.s.*
 FOUR, grade 13 15 16 n.s.*
 H–H grade 3 4 2 0.016*
 Grade 1, n 7 (18.5%) 1 (6%) 6 (29%) n.s.#
 Grade 2, n 7 (18.5%) 1 (6%) 6 (29%) n.s #
 Grade 3, n 8 (21%) 6 (35%) 2 (9%) n.s #
 Grade 4, n 8 (21%) 3 (18%) 5 (24%) n.s #
 Grade 5, n 8 (21%) 6 (35%) 2 (9%) n.s #
 Fisher grade 3 4 3 n.s.*
 Grade 2, n 8 (21%) 3 (18%) 5 (24%) n.s.#
 Grade 3, n 12 (32%) 4 (24%) 8 (38%) n.s.#
 Grade 4, n 18 (47%) 10 (58%) 8 (38%) n.s.#
Therapeutic intervention
 Clipping, n 16 (42%) 9 (53%) 7 (41%) n.s.#
 Coiling, n 19 (50%) 6 (35%) 13 (62%) n.s.#
 Conservative treatment, n 3 (8%) 2 (12%) 1 (5%) n.s.#
Outcome and complications
 Neurological disorders at discharge, n 16 (42%) 8 (47%) 9 (43%) n.s.#
 DCI, n 13 (34%) 6 (35%) 7 (33%) n.s.#
 CV, n 14 (37%) 6 (35%) 8 (38%) n.s.#
 GOS score at discharge 4 3 5 0.013*
 Poor short-term outcome, n 10 (26%) 7 (41%) 3 (14%) n.s.#
 Mortality, n 9 (27%) 6 (35%) 3 (14%) n.s.#
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 CDEm on the contralateral side than ones with moderate 
aSAH [h:min]: 2:05 (2:04–5:20) versus 0:49 (0:44–2:12) 
p = 0.038. We observed that patients with poor short-
term outcome had a longer  CDEm on the ipsilateral side 
than ones with good short-term outcome [h:min]: 5:43 
(3:04–9:35) versus 1:47 (0:41–2:10), p = 0.018. According 
to the ROC curves for predicting a poor short-term out-
come, the cut-off value for the  CDEm on the contralateral 
side was 2:05[h:min] (Z = 2.026, p = 0.042, AUC = 0.718) 
and the cut-off value for a  CDEt on the contralateral side 
was 8:15[h:min] (Z = 2.065, p = 0.039, AUC = 0.721).
3.5  Multiple logistic regression model to predict 
short‑term mortality
The following parameters were used as predictors of poor 
short-term outcome in a multiple linear regression model: 
Fisher grades, Apache II grades, median ABP, median 
ipsilateral and contralateral  rSO2, median ipsilateral and 
Fig. 2  The cerebral desatura-
tion episode (CDE) on the 
ipsilateral side in a 41 year 
old woman with aSAH. The 
decrease in  rSO2 was related to 
worse cerebral autoregulation 
and was preceded by a drop 
in ABP. ABP arterial blood 
pressure, rSO2 regional cerebral 
oxygen saturation, TOxa tissue 
oxygenation index. In the Toxa 
risk panel disorders of cerebral 
autoregulation (TOxa > 0) are 
marked in black. The arrows 
indicate the starting point of a 
decrease in the signals
Table 2  Parameters of cerebral desaturation episodes (CDEs) calculated in the total group of aSAH patients, and in patients with good/poor 
short term-outcome and with severe/moderate aSAH
p-values less than 0.05 are marked in bold
CDEn the total number of cerebral desaturation episodes, CDEt the total time of cerebral desaturation episodes, CDEm the time of the longest 
cerebral desaturation episode; the differences were tested using the U Mann–Whitney test
Parameter Total group 
(n = 17)
Moderate aSAH 
(n = 10)
Severe aSAH 
(n = 7)
p-value Good outcome 
(n = 10)
Poor outcome 
(n = 7)
p-value
CDEn ipsilateral 
[a.u.]
3 (1–4) 3 (1–4) 1 (1–2) 0.132 3 (1–4) 2 (1–3) 0.483
CDEn contralateral 
[a.u.]
4 (2–7) 2 (2–4) 6 (3–12) 0.195 5 (2–7) 7 (2–12) 0.565
CDEt ipsilateral 
[h:min]
4:18 (2:40–6:13) 4:02 (2:47–5:07) 6:57 (1:41–12:20) 0.770 2:55 (0.41–4:13) 8:43 (4:27–12:20) 0.108
CDEt contralateral 
[h:min]
6:26 (1:28–10:35) 1:23 (1:19–4:17) 8:15 (6:26–8:55) 0.038 3:54 (1:19–6:26) 9:44 (8:15–10:35) 0.074
CDEm ipsilateral 
[h:min]
2:10 (1:25–3:28) 2:06 (1:25–2:46) 5:20 (1:41–9:35) 0.298 1:47 (0.41–2:10) 5:43 (3:04–9:35) 0.018
CDEm contralateral 
[h:min]
2:14 (0:52–5:04) 0:49 (0.44–2:12) 2:05 (2:04–5:20) 0.038 1:53 (0:46–2:12) 5:11 (2:05–10:35) 0.100
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contralateral TOxa, occurrence of CA disorders,  CDEm and 
 CDEt on the contralateral side, dichotomised based on ROC 
curve thresholds for a poor short-term outcome. Among all 
the possible subsets of predictors, the model with the high-
est likelihood based on maximum likelihood estimation was 
chosen. The poor short-term outcome logistic regression 
model included the extent of haemorrhage on the Fisher 
scale, median ABP, and  CDEm on the contralateral side as 
a binary variable (see Table 3). The model was statistically 
significant: Likelihood–Ratio test: 18.13, p = 0.0004,  R2 
Cox–Snell: 0.38,  R2 Negelkerke: 0.55, Hosmer–Lemeshow 
test: 6.85, p = 0.55. The area under the ROC Curve was 
0.868 ± 0.071, showing that the model had good discrimi-
nation ability.
4  Discussion
Our results indicate that the time-related parameters of 
CDEs, namely: the total time of CDEs  (CDEt) and the time 
of the longest CDE  (CDEm) were longer in patients with 
severe aSAH, classified by the H–H scale. Moreover, a 
longer  CDEm was related to poor short-term outcome.
It has been shown in previous studies that long cerebral 
desaturation events during cardiosurgical operations may 
lead to increased morbidity, mortality [24], neurocognitive 
disorders [25] or postoperative cognitive dysfunction [26]. 
The duration of the ischemia is a critical determinant of tis-
sue damage, thus only a CDE which exceeds a time thresh-
old may have a significant impact on brain condition, cause 
neurological disorders or lead to a worse outcome. In our 
study, the threshold value of a  CDEm on the contralateral 
side was 2 h 5 min. This result is consistent with previous 
studies. It has been shown in research on pigs that the time 
of a CDE should be at least 2 h to result in neurological 
injury [24]. However, another analysis of 265 patients after 
coronary artery bypass grafting, revealed that a CDE lasting 
at least 50 min could result in cognitive decline or a longer 
hospital stay [25]. Thus, the critical threshold of the CDE 
time requires further investigation in a large cohort of aSAH 
patients.
Our results also indicated that CDEs were longer and 
occurred more often in patients with severe aSAH, con-
trary to the ones with moderate aSAH. It is noteworthy that 
patients with severe aSAH often have extended haemor-
rhage, which directly impacts cerebral blood flow and cer-
ebral metabolic rate. Cerebral oxygenation could be reduced 
as the direct neurotoxic result of subarachnoid blood and 
caspase-dependent and caspase-independent death receptor 
elevation [26]. Furthermore, insufficient cerebral saturation 
could be the result of ischemic damage or reperfusion injury 
or a reduced metabolic rate which occurred in the first short 
acute phase of aSAH [3]. These findings imply that NIRS 
monitoring could be beneficial in patients classified as 4–5 
in the H–H scale.
In our study, the ipsilateral side and contralateral side 
were defined to differentiate the side of the brain affected 
by the aneurysm and CV. However, the results showed that 
changes in cerebral oxygenation were not restricted to the 
territory of the ruptured aneurysm or CV, but also involved 
other areas of the brain. In the acute phase of aSAH when 
the early brain injury occurred, signalling cascades initiated 
a blood–brain barrier disturbance, inflammatory activation, 
and oxidative stress in areas of the brain distant from the 
aneurysm location.
CA impairment, actuated by the hemodynamic discrep-
ancy between neurons and vessels and then contributing 
to reduced CBF, is commonly observed in aSAH [3]. We 
found that the CA was disturbed in about 70% of the total 
group of aSAH patients and accompanied the occurrence 
of a CDE. This observation is in line with previous studies, 
which showed that CA, assessed using TOxa was impaired 
after aSAH [27]. Moreover, we found that cerebrovascular 
autoregulation, evaluated using the PRx index, was impaired 
during CDEs. This observation is in line with another study 
which showed that the PRx index correlated with a state of 
CBF and  CMRO2, which was determined using PET [28].
The multiple logistic regression model with the highest 
likelihood based on MLE showed that a  CDEm above the 
critical threshold, the extent of haemorrhage in the Fisher 
scale and mean arterial blood pressure were predictors of 
a poor short-term outcome. However, only  CDEm on the 
contralateral side was statistically significant as parameter 
Table 3  The binary logistic 
regression model for predicting 
poor short-term outcome in 
38 patients with diagnosed 
aneurysmal subarachnoid 
haemorrhage (aSAH)
ABP arterial blood pressure, CDEm the time of the longest cerebral desaturation episode (CDE) expressed 
as a binary variable regarding the critical threshold
*According to the ROC curve the threshold value for  CDEm for the contralateral side as a predictor of 
poor-short term outcome was 2.08 [h] (Z = 2.026, p = 0.042, AUC = 0.718)
Model parameter Wald’s statistic p-value Adj OR 95% CI
Extent of haemorrhage in the 
Fisher scale [a.u.]
2.56 0.11 3.60 0.75–17.34
Mean ABP [mm Hg] 3.18 0.07 3.60 0.79–1.01
CDEm for contralateral side* 4.14 0.04 15.39 1.11–214.16
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(W = 4.14; p = 0.04; OR = 15.39) in the logistic regression 
model and the interpretation concerning the rest of the 
parameters (median ABP and the extent of haemorrhage on 
the Fisher scale) should be limited. The  CDEm above the 
critical threshold was the best predictor of short-term out-
come after aSAH, which suggests that the monitoring of the 
time-related parameters of CDEs may have beneficial prog-
nostic implications. The observation that the higher ABP 
may lead to worse short-term outcome is related with the 
ineffectiveness of induced hypertension (one of the triple-
H therapy, which was applied in our patients with cerebral 
vasospasm and these with delayed cerebral ischemia in order 
to improve cerebral circulation). One of the latest studies 
has shown that this treatment could be insufficient in aSAH 
patients with symptomatic vasoconstriction and elevated 
initial troponin I level, indicating neurogenic damage to the 
heart [29]. The Fisher grading has been shown to be a pre-
dictor of outcome in a previous study as related to a higher 
risk of vasospasm or delayed cerebral ischemia [30].
Moreover, there is no clearly defined clinical way of 
treating aSAH patients in ICU, and applied treatments are 
subject to constant criticism. ICP monitoring undoubtedly 
helps in maintaining the desired brain perfusion pressure, 
but is an invasive method and has its limitations. Transcra-
nial Doppler is effective in detecting the contraction of the 
large vessels, but we monitor patient for a short period of 
time (about 30 min). What happens to the patient during the 
remaining time, especially if they are intubated and require 
administering of sedative drugs remains an interesting issue. 
Data on this subject is very limited and there are no studies 
showing that the use of NIRS may improve the outcome 
in adult neurocritical patients. NIRS could be successfully 
applied to monitor regional cerebral oxygenation and CA in 
patients with aSAH for a long period of time [28] since it is 
easy to set up and maintain as well as cost-effective. NIRS 
could constitute a part of a multimodality neuromonitor-
ing in neurocritical care, thus it should be interpreted with 
other systemic variables  (PaO2,  PaCO2,  FiO2, mean arterial 
blood pressure) and brain-specific variables (CBF, cerebral 
vasospasm, cerebral autoregulation or brain tissue gradients 
for oxygen diffusion) [31].
The controversy about using NIRS in clinical practise has 
been related to the lack of a standard measurement proto-
col, from using different types of devices with a variety of 
implemented algorithms. Moreover, external factors such 
as cerebrospinal fluids or blood in the subarachnoid or sub-
dural space may have an effect on the measurements [9, 30]. 
Moreover, it has been shown that NIRS can monitor normal 
cerebral oxygenation values in patients with brain death [32, 
11, 33]. It has been hypothesized that normal rSO2 during 
prolonged cardiac arrest may be the result of the absence 
of cerebral metabolism, preservation of the extracranial 
circulation (NIRS device is significantly influenced by the 
oxygenation of the scalp and skull), or a maintained resid-
ual cerebral perfusion. There were 9 cases of death in our 
cohort, whereas rCD episodes occurred in 6 cases of death. 
Although we did not monitor signals up to the moment of 
patient’s death, we observed that the values of  rSO2 gradu-
ally decreased in 4 out of 6 cases of death and rCD episodes, 
accompanied by a significant and long-term impairment of 
the cerebral autoregulation.
However, there are several limitations to this analysis. 
Firstly, there are a lot of factors related to the treatment of a 
serious condition which may affect the monitored signals and 
parameters, even though they represent the real critical care 
environment: analgesia, sedatives, intravenous anaesthetics, 
and nursery manoeuvres [32]. Moreover, as it has been shown 
in previous research, the value of  rSO2 may be influenced by 
the depth and type of administered anaesthesia, the systemic 
arterial blood pressure, haematocrit, arterial carbon dioxide 
partial pressure  (PaCO2), arterial oxygen saturation  (SaO2), 
pH and temperature [33, 34]. In our study, the physiologi-
cal factors which could have had an effect on the  rSO2, were 
maintained in the recommended range for aSAH patients [14]. 
Furthermore, the entire group was drug-homogenous. Since 
all patients had extensive monitoring of systemic oxygenation, 
CO2, and hemoglobine levels and these values were main-
tained within normal range, we assumed that rSO2 changes 
result from disturbances in the circulation of the brain. Theo-
retically, the use of induced hypertension or improvement of 
cardiac output should improve rSO2; however, we did not 
notice improvement in all patients. In our study, CBFV sig-
nals were used to determine the cerebral vasospasm and were 
not measured routinely, but when required. Because CBFV 
was not monitored during the CDEs in the entire group we 
decided not to analyse the CBFV-based mean velocity index 
Mxa. Furthermore, it should be noted that an ICP sensor was 
introduced to the intracranial compartment during operation 
(surgical clipping of the aneurysm) and was not routinely 
implemented in aSAH patients, but when medically necessary 
in a fraction of the analysed group, thus we did not determine 
the PRx in the entire group of patients. In various clinical prac-
tices, cerebral desaturation episodes are defined using different 
thresholds for NIRS-based  rSO2 and time of duration. In a 
recent study about hemodynamic instability in the postopera-
tive period following cardiac surgery, a CDE was described as 
 rSO2 of less than 60% for at least 60 s [19]. In other research, 
 rSO2 of 60% to 65% was suggested as the threshold value [34] 
for a CDE after thoracic aortic surgery. Even lower values of 
cerebral saturation were proposed in one definition of a CDE, 
namely:  rSO2 below 50% in coronary artery bypass grafting 
[25] or  rSO2 less than 40% in patients undergoing cardiac sur-
gery with cardiopulmonary bypass [35]. The current opinions 
regarding the system of assessing patients’ outcomes differ 
among researchers/clinicians. One of the most popular scales 
used to assess the long-term outcome is modified Rankin 
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scale (mRS). However, in our study, we focused on the early 
results of the treatment, thus GOS scale was more adequate to 
assess the outcome [36, 37]. Nevertheless, other clinical scale 
to assess patients’ long-term outcome needs to be applied in 
further research concerning relationship between the regional 
cerebral desaturation episodes and outcome in aSAH patients. 
Finally, the analysed data comes from patients hospitalised 
between 2015 and 2017. Thus, the standards of post-operative 
care could have slightly changed in the past few years. The 
group of aSAH patients which were analysed in this study was 
limited and came from one medical centre. Further research 
is warranted to confirm and better evaluate the observations 
presented in this paper.
5  Conclusion
We have demonstrated that time-related parameters describing 
CDEs are related to short-term outcome and severity of aSAH. 
Our findings suggest that NIRS can be used as a valuable part 
of a bedside neuromonitoring and may provide additional 
information about regional cerebral oxygenation and cerebral 
autoregulation. The more we know about SAH-induced cer-
ebral desaturation, the more efficient treatment strategies can 
be developed in aSAH patients. However, many questions 
about the clinical usefulness of the NIRS still remain open 
for discussion.
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